KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 0.1%.

  • Regeneron Pharmaceuticals' Return on Capital Employed fell 200.0% to 0.1% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.1%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.1% for FY2025, which is 200.0% down from last year.
  • As of Q4 2025, Regeneron Pharmaceuticals' Return on Capital Employed stood at 0.1%, which was down 200.0% from 0.11% recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Capital Employed ranged from a high of 0.43% in Q4 2021 and a low of 0.1% during Q4 2025
  • Its 5-year average for Return on Capital Employed is 0.21%, with a median of 0.16% in 2023.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Return on Capital Employed surged by 1800bps in 2021, and later tumbled by -2500bps in 2022.
  • Regeneron Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.43% in 2021, then tumbled by -57bps to 0.19% in 2022, then decreased by -26bps to 0.14% in 2023, then decreased by -14bps to 0.12% in 2024, then dropped by -16bps to 0.1% in 2025.
  • Its Return on Capital Employed stands at 0.1% for Q4 2025, versus 0.11% for Q3 2025 and 0.11% for Q2 2025.